Evidence map›Paper›PMID 33233774›Full record

ArticleMolecules (Basel, Switzerland)2020

Functionalization of Polyethyleneimine with Hollow Cyclotriveratrylene and Its Subsequent Supramolecular Interaction with Doxorubicin.

Carmine Coluccini, Yoke Mooi Ng, Yves Ira A Reyes, Hsin-Yi Tiffany Chen, Yit Lung Khung

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Carmine ColucciniInstitute of New Drug Development, China Medical University, No. 91 Hsueh-Shih Road, Taichung 40402, Taiwan.
Yoke Mooi NgInstitute of New Drug Development, China Medical University, No. 91 Hsueh-Shih Road, Taichung 40402, Taiwan.
Yves Ira A ReyesDepartment of Engineering and System Science, National Tsing Hua University, Hsinchu 30013, Taiwan.
Hsin-Yi Tiffany ChenDepartment of Engineering and System Science, National Tsing Hua University, Hsinchu 30013, Taiwan.ORCID 0000-0002-9651-3200
Yit Lung KhungDepartment of Biological Science and Technology, No. 100, Jingmao 1st Rd, Beitun District, Taichung City 406, Taiwan.ORCID 0000-0001-6571-3034
China Medical University · TWNational Tsing Hua University · TW

Funding

Ministry of Science and Technology, Taiwan 107-2113-M-039-008-MY3Ministry of Science and Technology, Taiwan 108-2112-M-007-023-MY3Ministry of Science and Technology, Taiwan 109-2221-E-039-013-MY2
6 · The paper itself

Abstract

In this paper, a modified Cyclotriveratrylene was synthesized and linked to a branched Polyethylenimine, and this unique polymeric material was subsequently examined as a potential supramolecular carrier for Doxorubicin. Spectroscopic analysis in different solvents had shown that Doxorubicin was coordinated within the hollow-shaped unit of the armed Cyclotriveratrylene, and the nature of the host-guest complex revealed intrinsic Van der Waals interactions and hydrogen bonding between the host and guest. The strongest interaction was detected in water because of the hydrophobic effect shared between the aromatic groups of the Doxorubicin and Cyclotriveratrylene unit. Density functional theory calculations had also confirmed that in the most stable coordination of Doxorubicin with the cross-linked polymer, the aromatic rings of the Doxorubicin were localized toward the Cyclotriveratrylene core, while its aliphatic chains aligned closer with amino groups, thus forming a compact supramolecular assembly that may confer a shielding effect on Doxorubicin. These observations had emphasized the importance of supramolecular considerations when designing a novel drug delivery platform.

Indexed as

Cross-Linking ReagentsDoxorubicinDrug CarriersDrug Delivery SystemsMacromolecular SubstancesMagnetic Resonance SpectroscopyModels, TheoreticalMolecular ConformationMolecular StructurePolycyclic CompoundsPolyethyleneiminePolymersSpectroscopy, Fourier Transform InfraredCross-Linking ReagentscyclotriveratryleneDoxorubicinDrug CarriersMacromolecular SubstancesPolycyclic CompoundsPolyethyleneiminePolymersarmed CyclotriveratryleneDoxorubicin loadingsupramolecular interaction

Identifiers

PMID33233774
PMCPMC7699908
OpenAlexW3105570802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.